Christopher Doe

1.1k total citations
21 papers, 579 citations indexed

About

Christopher Doe is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Christopher Doe has authored 21 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 9 papers in Molecular Biology and 5 papers in Physiology. Recurrent topics in Christopher Doe's work include Heart Rate Variability and Autonomic Control (4 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (3 papers) and Cardiovascular Disease and Adiposity (3 papers). Christopher Doe is often cited by papers focused on Heart Rate Variability and Autonomic Control (4 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (3 papers) and Cardiovascular Disease and Adiposity (3 papers). Christopher Doe collaborates with scholars based in United States, United Kingdom and Italy. Christopher Doe's co-authors include Robert N. Willette, David J. Behm, Stephen A. Douglas, Charles J. Prestigiacomo, Douglas G. Johns, Chirag D. Gandhi, Krystal L. Tomei, Kristeen Maniscalco, Zhaohui Ao and Ross Bentley and has published in prestigious journals such as Journal of Medicinal Chemistry, British Journal of Pharmacology and American Journal of Physiology-Heart and Circulatory Physiology.

In The Last Decade

Christopher Doe

21 papers receiving 563 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Doe United States 14 220 199 139 113 85 21 579
Bernd J. Zünkler Germany 14 195 0.9× 359 1.8× 230 1.7× 112 1.0× 56 0.7× 22 680
Masami Ohmori Japan 14 127 0.6× 110 0.6× 98 0.7× 53 0.5× 46 0.5× 38 558
Victor Skrinska United States 16 115 0.5× 110 0.6× 85 0.6× 97 0.9× 68 0.8× 32 547
Bassam Omar United States 12 172 0.8× 134 0.7× 69 0.5× 35 0.3× 83 1.0× 43 583
Annette Bak Netherlands 15 233 1.1× 106 0.5× 85 0.6× 133 1.2× 69 0.8× 19 692
James Tomlinson United Kingdom 13 114 0.5× 169 0.8× 67 0.5× 56 0.5× 231 2.7× 27 587
N. Dowd Ireland 11 253 1.1× 53 0.3× 226 1.6× 125 1.1× 60 0.7× 22 747
Gabriella Baldi Italy 13 181 0.8× 134 0.7× 38 0.3× 40 0.4× 62 0.7× 27 578
Leila Seres Hungary 10 114 0.5× 74 0.4× 211 1.5× 217 1.9× 71 0.8× 17 551
Michael Gwilt United Kingdom 10 367 1.7× 362 1.8× 52 0.4× 42 0.4× 67 0.8× 20 717

Countries citing papers authored by Christopher Doe

Since Specialization
Citations

This map shows the geographic impact of Christopher Doe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Doe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Doe more than expected).

Fields of papers citing papers by Christopher Doe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Doe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Doe. The network helps show where Christopher Doe may publish in the future.

Co-authorship network of co-authors of Christopher Doe

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Doe. A scholar is included among the top collaborators of Christopher Doe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Doe. Christopher Doe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wallace, Alex, et al.. (2020). Ergonomics in IR. Journal of Vascular and Interventional Radiology. 32(2). 235–241. 6 indexed citations
2.
Ryu, Robert K. & Christopher Doe. (2016). Anatomic and Technical Considerations: Inferior Vena Cava Filter Placement. Seminars in Interventional Radiology. 33(2). 88–92. 13 indexed citations
3.
Aparici, Mònica, Amadeu Gavaldà, Israel Ramos, et al.. (2015). In vitro and in vivo preclinical profile of abediterol (LAS100977), an inhaled long-acting β2-adrenoceptor agonist, compared with indacaterol, olodaterol and vilanterol. European Journal of Pharmacology. 770. 61–69. 19 indexed citations
4.
Tomei, Krystal L., Christopher Doe, Charles J. Prestigiacomo, & Chirag D. Gandhi. (2012). Comparative analysis of state-level concussion legislation and review of current practices in concussion. Neurosurgical FOCUS. 33(6). E11–E11. 57 indexed citations
5.
Simpson, R. David, Jing Yuan, Zhenrong Xu, et al.. (2011). Discovery of VTP-27999, an Alkyl Amine Renin Inhibitor with Potential for Clinical Utility. ACS Medicinal Chemistry Letters. 2(10). 747–751. 29 indexed citations
6.
Doe, Christopher, Pinakin R. Jethwa, Chirag D. Gandhi, & Charles J. Prestigiacomo. (2011). Strategies for asymptomatic carotid artery stenosis. Neurosurgical FOCUS. 31(6). E9–E9. 2 indexed citations
7.
Heath, Bryony, et al.. (2010). Translation of flecainide- and mexiletine-induced cardiac sodium channel inhibition and ventricular conduction slowing from nonclinical models to clinical. Journal of Pharmacological and Toxicological Methods. 63(3). 258–268. 35 indexed citations
8.
Sehon, Clark A., Andrew Q. Viet, Krista Goodman, et al.. (2008). Potent, Selective and Orally Bioavailable Dihydropyrimidine Inhibitors of Rho Kinase (ROCK1) as Potential Therapeutic Agents for Cardiovascular Diseases. Journal of Medicinal Chemistry. 51(21). 6631–6634. 63 indexed citations
9.
Bao, Weike, David J. Behm, Sandhya S. Nerurkar, et al.. (2007). Effects of p38 MAPK Inhibitor on Angiotensin II-Dependent Hypertension, Organ Damage, and Superoxide Anion Production. Journal of Cardiovascular Pharmacology. 49(6). 362–368. 89 indexed citations
10.
Jucker, Beat M., Christopher Doe, Christine G. Schnackenberg, et al.. (2007). PPARδ Activation Normalizes Cardiac Substrate Metabolism and Reduces Right Ventricular Hypertrophy in Congestive Heart Failure. Journal of Cardiovascular Pharmacology. 50(1). 25–34. 31 indexed citations
11.
Behm, David J., Gerald P. Stankus, Christopher Doe, et al.. (2006). The peptidic urotensin‐II receptor ligand GSK248451 possesses less intrinsic activity than the low‐efficacy partial agonists SB‐710411 and urantide in native mammalian tissues and recombinant cell systems. British Journal of Pharmacology. 148(2). 173–190. 32 indexed citations
12.
Maniscalco, Kristeen, Gerald P. Stankus, Robert N. Willette, et al.. (2004). Urotensin-II: a novel systemic hypertensive factor in the cat. Naunyn-Schmiedeberg s Archives of Pharmacology. 369(3). 274–280. 33 indexed citations
13.
Behm, David J., Stephen Harrison, Zhaohui Ao, et al.. (2003). Deletion of the UT receptor gene results in the selective loss of urotensin‐II contractile activity in aortae isolated from UT receptor knockout mice. British Journal of Pharmacology. 139(2). 464–472. 49 indexed citations
14.
Doe, Christopher, et al.. (2002). A method for QT correction based on beat-to-beat analysis of the QT/RR interval relationship in conscious telemetred beagle dogs. Journal of Pharmacological and Toxicological Methods. 48(1). 11–19. 34 indexed citations
15.
Smith, Andrew H., et al.. (2000). Tachycardia-induced primate model of heart failure in cardiovascular drug discovery. Journal of Pharmacological and Toxicological Methods. 43(2). 125–131. 1 indexed citations
16.
Forfia, Paul R., Xiao–Ping Zhang, Delvin R. Knight, et al.. (1999). NO modulates myocardial O2consumption in the nonhuman primate: an additional mechanism of action of amlodipine. American Journal of Physiology-Heart and Circulatory Physiology. 276(6). H2069–H2075. 21 indexed citations
17.
Doe, Christopher, et al.. (1998). Reflex vascular responses in the anesthetized dog to large rapid changes in carotid sinus pressure. American Journal of Physiology-Heart and Circulatory Physiology. 275(4). H1169–H1177. 9 indexed citations
18.
Drinkhill, Mark J., et al.. (1997). Reflex vascular responses to alterations in abdominal arterial pressure and flow in anaesthetized dogs. Experimental Physiology. 82(6). 995–1005. 1 indexed citations
19.
Doe, Christopher, et al.. (1996). Reflex vascular responses to abdominal venous distension in the anesthetized dog. American Journal of Physiology-Heart and Circulatory Physiology. 271(3). H1049–H1056. 15 indexed citations
20.
Hainsworth, R., et al.. (1994). An acute animal model that simulates the hemodynamic situations present during +Gz acceleration.. PubMed. 65(5 Suppl). A80–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bernd J. Zünkler Breakdown of academic impact, for papers by Masami Ohmori Breakdown of academic impact, for papers by Victor Skrinska Breakdown of academic impact, for papers by Bassam Omar Breakdown of academic impact, for papers by Annette Bak Breakdown of academic impact, for papers by James Tomlinson Breakdown of academic impact, for papers by N. Dowd Breakdown of academic impact, for papers by Gabriella Baldi Breakdown of academic impact, for papers by Leila Seres Breakdown of academic impact, for papers by Michael Gwilt
Rankless by CCL
2026